Over the past decade, management of common urological problems has metamorphosed in the field of female urology and voiding dysfunction; from treatment of routine stress urinary incontinence (SUI) with synthetic sling placement, to management of refractory overactive bladder (OAB) with neuromodulation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Nager, C. W. et al. A randomized trial of urodynamic testing before stress-incontinence surgery. N. Engl. J. Med. 366, 1987–1997 (2012).
Nilsson, C. G., Kuuva, N., Falconer, C., Retzapour, M. & Ulmsten, U. Longer-term results of the tension-free vaginal tape (TVT) procedure for surgical treatment of female stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 12, 5–8 (2001).
Nilsson, C. G., Palva, K., Aarnio, R., Morcos, E. & Falconer, C. Seventeen years' follow-up of the tension-free vaginal tape procedure for female stress urinary incontinence. Int. Urogynecol. J. Pelvic Floor Dysfunct. 24, 1265–1269 (2013).
Nager, C., Tulikangas, P., Miller, D. & Goldman, H. Position statement on mesh midurethral slings for stress urinary incontinence. Female Pelvic Med. Reconstr. Surg. 3, 123–125 (2014).
Richter, H. E. et al. Retropubic versus transobturator midurethral slings for stress incontinence. N. Engl. J. Med. 362, 2066–2076 (2010).
Gormley, E. A. et al. Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J. Urol. 188, 2455–2463 (2012).
Nitti, V. W. et al. Onabotulinum toxin A for the treatment of patients with overactive bladder and urinary incontinence: results of a phase 3, randomized, placebo controlled trial. J. Urol. 189, 2186–2193 (2013).
Schurch, B. et al. Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J. Urol. 174, 196–200 (2005).
Peters, K. M. et al. Randomized trial of percutaneous tibial nerve stimulation versus sham efficacy in the treatment of overactive bladder syndrome: results from the SUmiT Trial. J. Urol. 183, 438–443 (2010).
van Kerrebroeck, P. E. et al. Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study. J. Urol. 178, 2029–2034 (2007).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
H.B.G. is a consultant and speaker for Allergan, Medtronic and Uroplasty and a speaker for Astellas, M.M.C. declares no competing interests.
Rights and permissions
About this article
Cite this article
Clifton, M., Goldman, H. Advances in female urology and voiding dysfunction. Nat Rev Urol 11, 613–614 (2014). https://doi.org/10.1038/nrurol.2014.279
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2014.279
